Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|February 10, 2009
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonistsHao Zhang, Denis E Ryono, Pratik Devasthale, et al.
Infectious Diseases and Therapy|June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
The New England Journal of Medicine|January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile InfectionPaul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2015
Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studiesPratik Devasthale, Wei Wang, James Mignone, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
Dihydropyrrolopyrazol-6-one MCHR1 antagonists for the treatment of obesity: Insights on in vivo efficacy from a novel FLIPR assay setupPratik Devasthale, Wei Wang, Andres S Hernandez, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 2015
Synthesis and biological evaluation of novel pyrrolidine acid analogs as potent dual PPARα/γ agonistsHao Zhang, Charles Z Ding, Zhi Lai, et al.
Open Forum Infectious Diseases|May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary InfectionsDaniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Journal of Medicinal Chemistry|August 29, 2014
Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidateWilliam N Washburn, Mark Manfredi, Pratik Devasthale, et al.
The New England Journal of Medicine|June 13, 2019
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and EncephalitisMichael R Wilson, Hannah A Sample, Kelsey C Zorn, et al.
Pageof 10